515
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Doxorubicin-induced female reproductive toxicity: an assessment of ovarian follicular apoptosis, cyclicity and reproductive tissue histology in Wistar rats

, , &
Pages 72-81 | Received 27 Jan 2016, Accepted 08 Mar 2017, Published online: 25 Apr 2017

References

  • Abdella, E.M. and Ahmed, R., 2012. Suppression of doxorubicin apoptotic, histopathologic, mutagenic and oxidative stress effects in male mice bone marrow and testis tissues by aqueous rosemary leaves extract. Iranian Journal of Cancer Prevention, 2, 35–49.
  • American Cancer Society. 2014–2015. Website: Total., U.S. Cancer Treatment & Survivorship. Available from: http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-042801.pdf.
  • Amzai, G. and Stojanovic, A., 2013. Preservation of fertility and of reproduction ability in lymphoma patients. Macedonian Journal of Medical Sciences, 6, 194–101.
  • Bechter, R., et al., 1987. Differential susceptibility of immature rat testes to doxorubicin at critical stages of maturation. Biochemical and functional assessment. Archives of Toxicology, 60, 415–421.
  • Ben-Aharon, I., et al., 2010. Doxorubicin-induced ovarian toxicity. Reproductive Biology and Endocrinology, 8, 20.
  • Boone, D.L. and Tsang, B.K., 1998. Caspase-3 in the rat ovary: localization and possible role in follicular atresia and luteal regression. Biology of Reproduction, 58, 1533–1539.
  • Chabner, B.A., Brunton, L.L., and Knollmann, B.C., 1996. Antineoplastic agents. In: J.G. Hardman and L.E. Limbird, eds. Goodman & Gilman's—the pharmacological basis of therapeutics. New York: McGraw-Hill, 233–287.
  • Chen, Y., et al., 2001. Role of mitochondrial dysfunction in S-(1.,2-dichlorovinyl)-l-cysteine-induced apoptosis. Toxicology and Applied Pharmacology, 170, 172–180.
  • Clementi, M.E., et al., 2003. Doxorubicin-derived metabolites induce release of cytochrome C and inhibition of respiration on cardiac isolated mitochondria. Anticancer Research, 23, 2445–2450.
  • Conklin, K.A., 2004. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integrative Cancer Therapies, 3, 294–200.
  • Cooper, R.L., Goldman, J.M., and Vandenbergh, J.G., 1993. Monitoring of estrous cycle in the laboratory rodent by vaginal lavage. In: J.J. Heindel and R.E. Chapin, eds. Methods in toxicology female reproductive toxicology. San Diego: Academic Press, 57–558.
  • Cummings, B.S. and Schnellmann, R.G., 2002. Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways. Journal of Pharmacology and Experimental Therapeutics, 302, 8–17.
  • Damani, M.N., et al., 2002. Postchemotherapy ejaculatory azoospermia: fatherhood with sperm from testis tissue with intracytoplasmic sperm injection. Journal of Clinical Oncology, 20, 930–936.
  • De Assis, S., et al., 2010. Changes in mammary gland morphology and breast cancer risk in rats. Journal of Visualized Experiments, 44, e2260.
  • El-Mahdy Sayed Othman, O., 2000. Cytogenetic effect of the anticancer drug epirubicin on Chinese hamster cell line in vitro. Mutation Research, 468, 109–115.
  • Flaws, J.A., et al., 2001. Effect of bcl-2 on the primordial follicle endowment in the mouse ovary. Biology of Reproduction, 64, 1153–1159.
  • Gewirtz, D.A., 1999. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics Adriamycin and daunorubicin. Biochemical Pharmacology, 57, 727–741.
  • Gonfloni, S., et al., 2009. Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death. Nature Medicine, 15, 1179–1185.
  • Hajji, N., et al., 2005. Induction of genotoxic and cytotoxic damage by aclarubicin., a dual topoisomerase inhibitor. Mutation Research, 583, 26–35.
  • Kerr, J.B., et al., 2012. DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa. Molecular Cell, 48, 343–352.
  • Khan, F., Sherwani, A.F., and Afzal, M., 2009. Chromosomal aberration and micronucleus studies of two topoisomerase (II) targeting anthracyclines. Journal of Environmental Biology, 30, 409–412.
  • Konopa, J., 1988. G2 block induced by DNA crosslinking agents and its possible consequences. Biochemical Pharmacology, 37, 2303–2309.
  • Kotamraju, S., et al., 2004. Oxidant-induced iron signaling in doxorubicin-mediated apoptosis. Methods in Enzymology, 378, 362–382.
  • Krajewska, M., et al., 1997. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. Cancer Research, 57, 1605–1613.
  • L'Ecuyer, T., et al., 2006. DNA damage is an early event in doxorubicin-induced cardiac myocyte death. American Journal of Physiology, Heart and Circulatory Physiology, 291, H1273–H1280.
  • Livera, G., et al., 2008. p63 null mutation protects mouse oocytes from radio-induced apoptosis. Reproduction, 135, 3–12.
  • Marcello, M.F., et al., 1999. Structural and ultrastructural study of the ovary in childhood leukemia after successful treatment. Cancer, 66, 2099–2004.
  • Marcondes, F.K., et al., 2001. Estrous cycle influences the response of female rats in the elevated plus-maze test. Physiology & Behavior, 74, 435–440.
  • Meirow, D., et al., 2001. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Human Reproduction, 16, 632–637.
  • Migliore, L., et al., 1987. Cytogenetic damage induced in human lymphocytes by Adriamycin and vincristine: a comparison between micronucleus and chromosomal aberration assays. Toxicology in Vitro, 1, 247–254.
  • Mishra, O. and Bhiwgade, A., 2007. Doxorubicin mediated oxidative stress induced degeneration of testicular tissues, causes male sterility in rats. Journal of Cell and Tissue Research, 7, 861–866.
  • Mizutani, H., et al., 2005. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sciences, 76, 1439–1453.
  • Morita, Y., et al., 2000. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nature Medicine, 6, 1109–1114.
  • Oktay, K. and Oktem, O., 2007. A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve. Cancer Research, 86, 10159–10162.
  • Papandile, A., et al., 2004. Analysis of caspase-3., caspase-8 and caspase-9 enzymatic activities in mouse oocytes and zygotes. Zygote, 12, 57–64.
  • Perez, G.I., et al., 1997. Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction. Nature Medicine, 3, 1228–1232.
  • Pieniążek, A., et al., 2013. Oxidative stress induced in rat liver by anticancer drugs doxorubicin, paclitaxel and docetaxel. Advances in Medical Sciences, 58, 104–111.
  • Quinn, G.P., et al., 2008. Patient-physician communication barriers regarding fertility preservation among newly diagnosed cancer patients. Social Science & Medicine, 66, 784–789.
  • Richter, K.S., et al., 2007. Relationship between endometrial thickness and embryo implantation, based on 1,294 cycles of in vitro fertilization with transfer of two blastocyst-stage embryos. Fertility and Sterility, 87, 53–59.
  • Rudmann, D.G., and Foley, G.L., 2013. Female reproductive system. In: W.M. Haschek, C.G. Rousseaux, and M.A. Wallig, eds. Haschek and Rousseaux’s Handbook of Toxicologic Pathology, Elsevier Inc., London: Academic Press, pp. 2599–2663.
  • Schuler, M., et al., 2000. p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. The Journal of Biological Chemistry, 275, 7337–7342.
  • Serafino, A., et al., 1999. In duction of apoptosis in neoplastic cells by anthracycline antitumor drugs: nuclear and cytoplasmic triggering? Anticancer Research, 19, 1909–1918.
  • Serafino, A., et al., 1998. Cytoplasmic localization of anthracycline antitumor drugs conjugated with reduced glutathione: a possible correlation with multidrug resistance mechanisms. Anticancer Research, 18, 1159–1166.
  • Shinoda, K., Mitsumori, K., and Yasuhara, K., 1999. Doxorubicin induces male germ cell apoptosis in rats. Archives of Toxicology , 73, 274–281.
  • Smith, M.L. and Suresh Kumar, M.A., 2010. The “two faces” of tumor suppressor p53-revisited. Molecular and Cellular Pharmacology, 2, 117–119.
  • Sonmezer, M. and Oktay, K., 2006. Fertility preservation in young women undergoing breast cancer therapy. Oncologist, 11, 422–434.
  • Suzuki, H. and Nakane, S., 1994. Differential induction of chromosomal aberrations by topoisomerase inhibitors in cultured Chinese hamster cells. Biological and Pharmaceutical Bulletin, 17, 222–226.
  • Swamy, A.V., et al., 2012. Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats. Indian Journal of Pharmacology, 44, 73–77.
  • Takai, Y., et al., 2003. Bax., caspase-2., and caspase-3 are required for ovarian follicle loss caused by 4-vinylcyclohexene diepoxide exposure of female mice in vivo. Endocrinology, 144, 69–74.
  • Tritton, T.R., Yee, G., and Wingard Jr, L.B., 1983. Immobilized adriamycin: a tool for separating cell surface from intracellular mechanisms. Federation Proceedings, 42, 284–8287.
  • Vendramini, V., Sasso-Cerri, E., and Miraglia, S.M., 2010. Amifostine reduces the seminiferous epithelium damage in doxorubicin-treated prepubertal rats without improving the fertility status. Reproductive Biology and Endocrinology, 8, 3.
  • Yuksel, A., et al., 2015. The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells. Human Reproduction, 30, 2926–2935.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.